Amendment # 2 to Clinical Trial Agreement Dodatek # 2 ke Smlouvě o provedení klinického hodnoceníClinical Trial Agreement • April 27th, 2017
Contract Type FiledApril 27th, 2017This Amendment # 2 (the “Amendment # 2 ) by and among ARAGON PHARMACEUTICALS, INC, with offices located at 12780 El Camino Real, Suite 301, San Diego, CA 92130 ("Sponsor") and Fakultní nemocnice Olomouc, located at I.P.Pavlova 185/6, 779 00, Olomouc, Czech Republic, ID number: 00098892, TAX ID number: CZ00098892, represented by prof. MUDr. Roman Havlík, Ph.D., director (“Institution”) and Pharmaceutical Research Associates CZ, s.r.o. located at Jankovcova 1569/2c, 170 00 Praha 7, Czech Republic, Company ID No.: 276 36 852, Tax ID No.: CZ27636852, acting by MUDr. Andrea Klč, proxy (“PRA”), an affiliate of Pharmaceutical Research Associates, Inc, 4130 ParkLake Avenue, Suite 400, Raleigh, North Carolina 27612, USA (“PRA Inc.”), is made valid as of the date of execution that the last party signs below and is made effective on day of its publication if Register of Contracts in compliance with Act 340/2015 Coll., on Register of Contracts (hereinafter “Effective Date”). PRA has agreed t